SUMMARY The presence of excess aluminium was investigated in 204 samples of iliac bone from 197 patients with chronic renal failure by using the aluminon and solochrome azurine staining techniques. The results were compared with values obtained by atomic absorption spectrophotometry (AAS). Overall, the staining reactions correlated with the AAS data, but the solochrome azurine stain was positive more often than was the aluminon stain (in 90-6% and 62-3%, respectively, of bone samples with greater than the control group mean + 3SD (that is, in the range 17-8 to 113-4 pg aluminium/g bone). Solochrome azurine staining was consistently positive in all cases, with > 23-1 pg aluminium/g bone but the corresponding aluminon stain was occasionally inexplicably negative in this range. In some samples solochrome azurine was positive in parts of old unresorbed cement lines when the aluminon stain was negative and the bone aluminium concentration was within the normal range or slightly increased.
Bone disease caused by aluminium deposits is a well recognised complication of renal failure in patients treated by dialysis or with oral aluminium hydroxide."3 Aluminon is often used to show or quantify aluminium in sections of undecalcified bone.'9 Clark and Krueger emphasised that aluminon is not a specific reagent for aluminium and concluded that its histochemical application requires verification by quantitative techniques.'" In our experience positive aluminon staining is easily recognisable when the bone aluminium content (measured by neutron activation analysis) is high,5 as in patients with osteomalacia induced by aluminium and in animals injected with aluminium chloride.3 With lesser amounts of aluminium in bone, interpretation may be difficult. More recently solochrome azurine staining has been advocated to show aluminium in sections of undecalcified bone." We routinely use both the solochrome azurine and aluminon techniques and have found solochrome azurine much easier to interpret. To further investigate their sensitivity and specificity we Accepted for publication 19 May 1988 undertook a comparative study of the two staining methods and correlated the results obtained with values for bone aluminium determined by flameless atomic absorption spectrophotometry (AAS). As aluminon and solochrome azurine may react with iron' " all bone samples were stained also with Perls's stain.
Material and methods
Transiliac bone biopsy specimens (7 mm Control mean (SD) 7-6 (3.4)/pg/g (n = 27). *Significantly increased compared with samples from controls and predialysis group (p < 0-001).
Ellis, Pang, Mawhinney, Skillen or solochrome azurine (27 samples) stains were positive. Although in 14 of the 27 samples the aluminium content was greater than the upper limit of the control group (13-3 ug/g), in the remaining 13, aluminium values were within the normal range. The aluminon stain was positive in only three samples-in cement lines in two and additionally in the mineralisation front in the third. The solochrome azurine stain was positive in all 13 samples-in old cement lines in 10 and in both cement lines and mineralisation fronts in three. A total of 129 samples had aluminium values within the reference range, giving "false" positive staining rates of 2-3% and 10-1%, respectively, for aluminon and solochrome azurine staining reactions. The corresponding "false" positive rates were 1-5% and 6-4% for the 204 samples.
Variable amounts of stainable iron pigment were present within marrow macrophages in 150 (73-5%) bone samples and in the tissue lining trabecular bone surfaces in 85 (41-7%). The presence of iron did not seem to affect the staining reactions for aluminium in bone. The positive Perls's reaction was almost invariably located at the bone surface (endosteum); the stains for aluminium were positive at the interface between osteoid and mineralised bone and in cement lines. There was only one sample in which some cement lines stained positively with both aluminon and solochrome azurine and by the Perls's technique.
Discussion
Earlier studies reported from this hospital were concerned with patients on haemodialysis with osteomalacia induced by aluminium.3 The bones were shown to contain great excesses of aluminium by neutron activation analysis. The present study was deliberately restricted to samples in which relatively small increases ofbone aluminium were expected as we were especially interested in determining the sensitivity of the aluminon and solochrome azurine stains and osteomalacia was present in only one predialysis and seven dialysis patients (table 4). Varying degrees of intensity of staining were noted with generally more intense staining in the bones, which were subsequently shown by AAS to have the higher concentrations of aluminium. The intensity of the staining reaction, for example with aluminon, is not strictly linearly related to the concentration of aluminium'°and for the present we were concerned only to determine whether the individual stain was positive and its location. The study shows clearly that aluminon gives a positive reaction less often than does solochrome azurine in samples shown by AAS to have an increased aluminium content. This is especially the case with lesser amounts of aluminium in the bone within the range studied. We agree with Denton et af' that solochrome azurine staining indicates a more extensive distribution of aluminium in both compact and cancellous bone than is often apparent with aluminon.
With regard to sensitivity, there was no precise cut off point at one aluminium concentration with either the aluminon or solochrome azurine stains. All of our samples with bone aluminium of more than 23-1 pg/g gave a positive stain with solochrome azurine. In those positive samples with less than 23-1 pg/g aluminium the stain was generally less intense or confined to parts ofold cement lines. Small localised deposits ofaluminium shown by solochrome azurine would not be expected to give rise to an overall increase in bone aluminium content, and the "false" positive rate for the solochrome azurine staining reaction (10-1%) is probably unduly high. Our cut off point seems to be similar to that reported by Denton et a!' who noted positive solochrome azurine staining when bone aluminium was in the range 16 to 406, mean 141 pg/g. Fifty three (86-9%) of our samples with bone aluminium of more than 16 pg/g had positive solochrome azurine stains.
Results with the aluminon stain tended to be capricious. Sometimes increased amounts of alumin-Ellis, Pang, Mawhinney, Skillen ium by AAS were clearly visible with solochrome azurine whereas the aluminon stain was repeatedly negative. Sporadic negative aluminon stains were noted in individual cases, with up to 63.9 pg aluminium/g bone. Aluminon often failed to show aluminium in parts of old cement lines clearly defined by solochrome azurine. In the higher range of aluminium concentrations (more than 16 pg/g) the aluminon stain was positive in 35 (57.4%) samples. There is no clear explanation for the discrepancy between solochrome azurine and aluminon staining, or for the occasional failure of both stains in bone with increased aluminum content. There is no obvious reason to suspect the spectrophotometric data. The possibility that the occasional specimen was contaminated during the preparations for AAS analysis cannot be completely excluded but seems unlikely as all specimens were handled in the same manner. Furthermore, others have noted the phenomenon of a negative aluminon stain when bone aluminium has been shown by AAS to be increased."'5 Possibly, some unrecognised substance interferes in the aluminon complex formed with aluminium.
The aluminon and solochrome azurine stains are not entirely specific for aluminium and may react with-for example, iron and beryllium.'`°In particular, iron, which is often present in excess amounts in the marrow macrophages of patients with renal disease, is relevant here. The darker brownish-red colour obtained with aluminon and iron, however, is readily distinguishable from the bright cherry-red associated with aluminium. Difficulty arises when both iron and aluminium are presumed to be colocated when the colour with aluminon is brownishred and the Perls's stain is positive. In such cases any doubt could be resolved by spectrophotometric analysis, or preferably, by microprobe studies." 6 Although, like others we have seen bone biopsy specimens from several patients with dialysis osteomalacia in which iron was present at the interface between osteoid and mineralised bone and where the aluminon staining gave rise to a reddish-brown colour,'7 in the present study the presence of iron did not interfere with interpretation of the staining reactions. The location of iron in bone was generally different from that of aluminium and in none of the present cases was there a positive Perls's reaction in the region of the mineralisation front. In only one sample was there a positive reaction for haemosiderin in cement lines which also stained in consecutive sections by both aluminon and solochrome azurine. The bone aluminium content of this sample was 9.8 pg/g, and in the absence of electron or laser microprobe analysis data we are uncertain whether the positive stains for aluminium were spurious due to reaction with iron alone or if both iron and aluminium were located in the same place at the same time.
We conclude that the aluminon and solochrome azurine staining techniques are suffiiciently "specific" and sensitive to be of clinical value in showing the presence ofexcess aluminium in undecalcified sections of bone biopsy specimens. Solochrome azurine is positive more often and indicates more widespread deposition of aluminium than is suggested by the aluminon stain. A positive reaction, in addition to showing or confirming the cause of any osteomalacia, may be the first indication that the patient is at possible risk from the effects of aluminium intoxication. Demonstration of stainable bone aluminium has certain advantages over serum aluminium data alone.'8 After exposure to aluminium the excess bone aluminium may persist for prolonged periods and still be present when the serum aluminium concentration has diminished. The staining techniques have the advantage over bone spectrophotometry in that they indicate the location of the excess bone aluminium, and the presence of aluminium in the region of the mineralisation fronts is of greater importance for mineralisation than are deposits deep in mineralised bone cement lines.
